FDA Approves Checkpoint’s Unloxcyt for Metastatic Cutaneous Squamous Cell Carcinoma: A Breakthrough in Skin Cancer Treatment

Checkpoint Therapeutics’ Unloxcyt (cosibelimab-ipdl) received FDA approval for treating metastatic cutaneous squamous cell carcinoma (cSCC). This is the first PD-L1 blocking antibody approved for this indication. Unloxcyt is administered intravenously at 1200 mg every three weeks. The approval comes after a previous setback related to manufacturing, not the drug’s efficacy or safety. CKPT stock saw a premarket surge following the news.

New Jersey Bill Aims to Make Sunscreen Accessible in Schools

A New Jersey assemblywoman has proposed a bill that would allow students to use sunscreen in schools. The bill comes in response to the state’s unique law that classifies sunscreen as an over-the-counter medication, limiting its availability in schools. The bill aims to address concerns about skin cancer prevention, highlighting the importance of sunscreen for children’s health and safety.

Merck Discontinues Two Phase 3 Trials for Keytruda Due to Ineffectiveness

Merck & Co Inc has discontinued two Phase 3 trials evaluating Keytruda (pembrolizumab) for the treatment of non-small cell lung cancer and cutaneous squamous cell carcinoma. The decision was based on recommendations from independent Data Monitoring Committees, which found that Keytruda did not demonstrate a statistically significant improvement in survival or recurrence-free survival compared to placebo.

Doctor Urges Daily UV Index Check to Prevent Skin Cancer

A doctor advises checking the UV index on your phone daily to minimize the risk of skin cancer. He explains that even in the UK, where the UV index is often around 3, fair-skinned individuals should consider sunscreen daily. The higher the UV index, the greater the risk of skin damage, and individuals should take precautions like wearing protective clothing and seeking shade.

Skin Cancer Diagnoses Reach Record High in the UK

Skin cancer diagnoses in the UK have reached a record high, with 20,800 people expected to be diagnosed with melanoma this year. The rates have increased by almost a third over the past decade. While anyone can get skin cancer, those with fair complexions are at a higher risk, but people with darker skin tones can also be affected. To prevent skin cancer, it’s important to limit exposure to ultraviolet (UV) radiation, check your skin regularly for any changes, and see your doctor if you notice any unusual moles or skin lesions.

Scroll to Top